Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Immunology and Allergy Clinics of North America|April 4, 2017
Patient Characteristics and Individualization of Biologic TherapySteven Draikiwicz, John Oppenheimer
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
Pageof 1